​

Funding Round

Series C - Vera Therapeutics

Series C - Vera Therapeutics

Investment Firm

Overview

Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.

Announced Date

Jan 19, 2021

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

Abingworth

Abingworth

Abingworth is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

8

Investor Name
Participant InvestorSofinnova Investments
Participant InvestorAbingworth
Participant InvestorKleiner Perkins
Participant InvestorGoogle Ventures
Participant InvestorFidelity

Round Details and Background

Vera Therapeutics raised $80000000 on 2021-01-19 in Series C

Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 10, 2022
Post-IPO Equity - Vera Therapeutics
-74.9M
Feb 01, 2023
Post-IPO Equity - Vera Therapeutics
-115.0M
Jan 01, 2021
Debt Financing - Vera Therapeutics
1-42.5M
Jan 29, 2024
Post-IPO Equity - Vera Therapeutics
-250.0M

Recent Activity

There is no recent news or activity for this profile.